{"title":"Hypocalcemia in critical care settings, from its clinical relevance to its treatment: A narrative review","authors":"Catarina Fernandes , Luciano Pereira","doi":"10.1016/j.accpm.2024.101438","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Hypocalcemia, measured through ionized calcium, is a common derangement in critically ill patients. Hypocalcemia is corrected as a routine procedure in intensive care units; however, no clear guidelines exist for its management.</div></div><div><h3>Objectives</h3><div>This narrative review aims to provide an overview of hypocalcemia in critical care settings. This includes its association with important clinical outcomes and the assessment of the need for its correction in critically ill patients in general and in two subgroups: those with trauma and sepsis.</div></div><div><h3>Methods</h3><div>An extensive article search on hypocalcemia in critically ill patients was performed using PubMed, Web of Science, Cochrane Library, and Google Scholar.</div></div><div><h3>Findings</h3><div>Several studies showed an association between hypocalcemia and high mortality and disease severity in critically ill patients. However, the scientific evidence concerning its correction remains conflicting. Most studies showed that calcium supplementation did not improve clinical outcomes, such as mortality, and in some cases, ionized calcium levels normalized without supplementation. Patients with trauma and sepsis are subgroups, with special characteristics that should be considered when treating hypocalcemia.</div></div><div><h3>Conclusions</h3><div>We concluded that hypocalcemia is associated with several important clinical outcomes. Treating severe hypocalcemia is generally recommended, whereas treating moderate or mild hypocalcemia can lead to higher mortality and organ dysfunction, outweighing the potential clinical benefits, particularly in patients with sepsis. Hence, multicenter clinical trials are needed to assess the efficacy and safety of hypocalcemia treatment in these patients.</div></div>","PeriodicalId":48762,"journal":{"name":"Anaesthesia Critical Care & Pain Medicine","volume":"43 6","pages":"Article 101438"},"PeriodicalIF":3.7000,"publicationDate":"2024-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Anaesthesia Critical Care & Pain Medicine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2352556824000961","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ANESTHESIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Hypocalcemia, measured through ionized calcium, is a common derangement in critically ill patients. Hypocalcemia is corrected as a routine procedure in intensive care units; however, no clear guidelines exist for its management.
Objectives
This narrative review aims to provide an overview of hypocalcemia in critical care settings. This includes its association with important clinical outcomes and the assessment of the need for its correction in critically ill patients in general and in two subgroups: those with trauma and sepsis.
Methods
An extensive article search on hypocalcemia in critically ill patients was performed using PubMed, Web of Science, Cochrane Library, and Google Scholar.
Findings
Several studies showed an association between hypocalcemia and high mortality and disease severity in critically ill patients. However, the scientific evidence concerning its correction remains conflicting. Most studies showed that calcium supplementation did not improve clinical outcomes, such as mortality, and in some cases, ionized calcium levels normalized without supplementation. Patients with trauma and sepsis are subgroups, with special characteristics that should be considered when treating hypocalcemia.
Conclusions
We concluded that hypocalcemia is associated with several important clinical outcomes. Treating severe hypocalcemia is generally recommended, whereas treating moderate or mild hypocalcemia can lead to higher mortality and organ dysfunction, outweighing the potential clinical benefits, particularly in patients with sepsis. Hence, multicenter clinical trials are needed to assess the efficacy and safety of hypocalcemia treatment in these patients.
背景:低钙血症(通过离子钙测量)是重症患者常见的失调。低钙血症的纠正是重症监护病房的常规程序,但目前尚无明确的管理指南:本综述旨在概述重症监护环境中的低钙血症。这包括低钙血症与重要临床结果的关联,以及对一般重症患者和两个亚组(创伤患者和败血症患者)纠正低钙血症需求的评估:方法:使用 PubMed、Web of Science、Cochrane Library 和 Google Scholar 对重症患者低钙血症的相关文章进行了广泛搜索:几项研究表明,低钙血症与危重病人的高死亡率和疾病严重程度有关。然而,有关纠正低钙血症的科学证据仍然相互矛盾。大多数研究表明,补充钙剂并不能改善死亡率等临床结果,在某些情况下,不补充钙剂也能使离子钙水平恢复正常。创伤和败血症患者属于亚组,在治疗低钙血症时应考虑其特殊性:我们得出的结论是,低钙血症与几种重要的临床结果有关。一般建议治疗重度低钙血症,而治疗中度或轻度低钙血症会导致更高的死亡率和器官功能障碍,得不偿失,尤其是对败血症患者而言。因此,需要进行多中心临床试验,以评估这些患者低钙血症治疗的有效性和安全性。
期刊介绍:
Anaesthesia, Critical Care & Pain Medicine (formerly Annales Françaises d''Anesthésie et de Réanimation) publishes in English the highest quality original material, both scientific and clinical, on all aspects of anaesthesia, critical care & pain medicine.